Assignee
BIONTECH AG
DE31 patents
Top patents by PatentIndex Score
US10106800B2Oct 23, 2018
Modification of RNA, producing an increased transcript stability and translation efficiency
BIONTECH AG18 citations93
US9533043B2Jan 3, 2017
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG7 citations83
US9267177B2Feb 23, 2016
Identification of tumor-associated cell surface antigens for diagnosis and therapy
BIONTECH AG6 citations83
US9194004B2Nov 24, 2015
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG6 citations82
US9950065B2Apr 24, 2018
Particles comprising a shell with RNA
BIONTECH AG12 citations81
US10604568B2Mar 31, 2020
Diagnosis and therapy of cancer involving cancer stem cells
BIONTECH AG6 citations80
US10093736B2Oct 9, 2018
Agents for treatment of claudin expressing cancer diseases
BIONTECH AG7 citations79
US10717780B2Jul 21, 2020
Agents for treatment of claudin expressing cancer diseases
BIONTECH AG5 citations78
US10980875B2Apr 20, 2021
Cytotoxic immunostimulating particles and uses thereof
BIONTECH AG2 citations73
US10724103B2Jul 28, 2020
Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy
BIONTECH AG1 citations71
US11787862B2Oct 17, 2023
Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases
BIONTECH AG3 citations68
US11628209B2Apr 18, 2023
Tumor antigens for determining cancer therapy
BIONTECH AG1 citations68
US10188712B2Jan 29, 2019
Tumor antigens for determining cancer therapy
BIONTECH AG3 citations68
US10253373B2Apr 9, 2019
Identification of tumor-associated markers for diagnosis and therapy
BIONTECH AG1 citations62
US10172960B2Jan 8, 2019
Particles comprising single stranded RNA and double stranded RNA for immunomodulation
BIONTECH AG1 citations62
US11795218B2Oct 24, 2023
Diagnosis and therapy of cancer involving cancer stem cells
BIONTECH AG0 citations59
US11008550B2May 18, 2021
Use of RNA for reprogramming somatic cells
BIONTECH AG0 citations59
US10370433B2Aug 6, 2019
Compositions and methods for diagnosis and treatment of cancer
BIONTECH AG1 citations58
US10858415B2Dec 8, 2020
Peptide mimotopes of claudin 18.2 and uses thereof
BIONTECH AG1 citations57
US10550430B2Feb 4, 2020
Method and kit for determining whether a subject shows an immune response
BIONTECH AG1 citations53
US10626400B2Apr 21, 2020
Stabilised formulations of RNA
BIONTECH AG0 citations52
US10457735B2Oct 29, 2019
Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains
BIONTECH AG0 citations52
US9637794B2May 2, 2017
Genetic products differentially expressed in tumors and use thereof
BIONTECH AG0 citations52
US10302647B2May 28, 2019
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG0 citations51
US9139880B2Sep 22, 2015
Identification of tumor-associated cell surface antigens for diagnosis and therapy
BIONTECH AG0 citations51
US9910043B2Mar 6, 2018
Identification of tumor-associated cell surface antigens for diagnosis and therapy
BIONTECH AG0 citations50
US10526387B2Jan 7, 2020
Tumor vaccination involving a humoral immune response against self-proteins
BIONTECH AG0 citations49
US9944708B2Apr 17, 2018
Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)
BIONTECH AG0 citations49
US9617321B2Apr 11, 2017
Tumor vaccination involving a humoral immune response against self-proteins
BIONTECH AG0 citations49
US9139639B2Sep 22, 2015
Polynucleotides encoding an intracellular segment of CD40 and a constant region of an immunoglobulin heavy chain
BIONTECH AG0 citations48
US9061007B2Jun 23, 2015
Compositions and methods for therapy and diagnosis of cancer and cancer metastasis
BIONTECH AG0 citations42